CHINA NATURAL RESOURCES INC (CHNR)

VGG2110U1176 - Common Stock

1  -0.11 (-9.91%)

After market: 1 0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CHNR. CHNR was compared to 155 industry peers in the Metals & Mining industry. CHNR has a bad profitability rating. Also its financial health evaluation is rather negative. CHNR does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

CHNR had negative earnings in the past year.
In the past year CHNR has reported a negative cash flow from operations.
In the past 5 years CHNR reported 4 times negative net income.
In the past 5 years CHNR always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of CHNR (-7.69%) is worse than 68.39% of its industry peers.
CHNR's Return On Equity of -36.28% is on the low side compared to the rest of the industry. CHNR is outperformed by 80.65% of its industry peers.
Industry RankSector Rank
ROA -7.69%
ROE -36.28%
ROIC N/A
ROA(3y)-5.85%
ROA(5y)-123.23%
ROE(3y)-28.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CHNR has a Gross Margin of 28.57%. This is in the better half of the industry: CHNR outperforms 69.68% of its industry peers.
In the last couple of years the Gross Margin of CHNR has grown nicely.
The Profit Margin and Operating Margin are not available for CHNR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y41.01%
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

CHNR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CHNR remains at a similar level compared to 1 year ago.
Compared to 5 years ago, CHNR has more shares outstanding
Compared to 1 year ago, CHNR has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -1.22, we must say that CHNR is in the distress zone and has some risk of bankruptcy.
CHNR's Altman-Z score of -1.22 is on the low side compared to the rest of the industry. CHNR is outperformed by 84.52% of its industry peers.
CHNR has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CHNR (1.07) is worse than 88.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF N/A
Altman-Z -1.22
ROIC/WACCN/A
WACC7.78%

2.3 Liquidity

CHNR has a Current Ratio of 3.04. This indicates that CHNR is financially healthy and has no problem in meeting its short term obligations.
CHNR's Current ratio of 3.04 is in line compared to the rest of the industry. CHNR outperforms 60.00% of its industry peers.
A Quick Ratio of 3.03 indicates that CHNR has no problem at all paying its short term obligations.
CHNR has a Quick ratio of 3.03. This is in the better half of the industry: CHNR outperforms 71.61% of its industry peers.
Industry RankSector Rank
Current Ratio 3.04
Quick Ratio 3.03

1

3. Growth

3.1 Past

CHNR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.41%, which is quite impressive.
CHNR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.56%.
Measured over the past years, CHNR shows a very negative growth in Revenue. The Revenue has been decreasing by -48.34% on average per year.
EPS 1Y (TTM)49.41%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-32.79%
Revenue 1Y (TTM)8.56%
Revenue growth 3Y-48.33%
Revenue growth 5YN/A
Revenue growth Q2Q-77.54%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CHNR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CHNR!.
Industry RankSector Rank
Dividend Yield N/A

CHINA NATURAL RESOURCES INC

NASDAQ:CHNR (4/19/2024, 7:00:00 PM)

After market: 1 0 (0%)

1

-0.11 (-9.91%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap9.87M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.69%
ROE -36.28%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 28.57%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.04
Quick Ratio 3.03
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)49.41%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)8.56%
Revenue growth 3Y-48.33%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y